Oncosil Medical Ltd has released a press release.
OncoSil Medical Receives MDR Approval
Filed with ASX ·
6ix hasn’t read this filing yet.
Story so far
Earlier from OncoSil Medical
- OncoSil receives $1.05m R&D tax incentive
- Oncosil completes $1 million Share Purchase Plan (SPP)
- Prospectus 2024 Share Purchase Plan (SPP) Offer
- OSL completes $7 M Placement and announces $1 M SPP
- G-BA Approval received for OncoSil Device
Later from OncoSil Medical
- 120 German Hospitals entitled to negotiate fee for OncoSil
- Consolidation/Split - OSL
- OSL announces $8.7m capital raise to drive commercialisation
- Completion of Recruitment in PANCOSIL Study
- Completion of Recruitment in TRIPP-FFX Clinical Trial
Follow OncoSil Medical into a list and get an email when it puts out news.
Follow OncoSil Medical